Showing results (161-170 of 286) with videos related to

Sort By:
Pageof 29
Pediatric Blood & Cancer|April 11, 2019
Unintended consequences of evolution of the Common Terminology Criteria for Adverse EventsTamara P Miller, Brian T Fisher, Kelly D Getz, et al.
Critical Care Medicine|July 16, 2019
Antimicrobial Disposition During Pediatric Continuous Renal Replacement Therapy Using an Ex Vivo ModelPrashant J Purohit, Mohammed H Elkomy, Adam Frymoyer, et al.
Antimicrobial Agents and Chemotherapy|August 20, 2014
Association between vancomycin trough concentration and area under the concentration-time curve in neonatesAdam Frymoyer, Adam L Hersh, Mohammed H El-Komy, et al.
Frontiers in Pediatrics|September 7, 2021
Improvement in Health-Related Quality of Life After Community Acquired Pediatric Septic ShockNeethi P Pinto, Robert A Berg, Athena F Zuppa, et al.
Cancer|May 13, 2004
High-dose methotrexate-induced nephrotoxicity in patients with osteosarcomaBrigitte C Widemann, Frank M Balis, Beate Kempf-Bielack, et al.
The AAPS Journal|September 10, 2015
Pharmacokinetics of Morphine and Its Metabolites in Infants and Young Children After Congenital Heart SurgeryMohammed H Elkomy, David R Drover, Kristi L Glotzbach, et al.
Critical Care (London, England)|September 6, 2023
Hyperferritinemic sepsis, macrophage activation syndrome, and mortality in a pediatric research network: a causal inference analysisZhenziang Fan, Kate F Kernan, Yidi Qin, et al.
Journal of Clinical Pharmacology|December 21, 2007
Population pharmacokinetic investigation of actinomycin-D in children and young adultsJohn T Mondick, Leonid Gibiansky, Marc R Gastonguay, et al.
The Oncologist|July 1, 2008
Characteristics and outcome of pediatric patients enrolled in phase I oncology trialsAerang Kim, Elizabeth Fox, Katherine Warren, et al.
Pageof 29